Document 0137
 DOCN  M95A0137
 TI    Adenovirus as vector for HIV: efficacy and safety issues.
 DT    9510
 AU    Natuk RJ; Wade MS; Chengalvala M; Murthy KK; Chanda PK; Murthy SC; Bhat
       BM; Bhat R; Dheer SK; Mizutani S; et al; Wyeth-Ayerst Research,
       Biotechnology and Microbiology Division,; Philadelphia, PA, USA.
 SO    Dev Biol Stand. 1995;84:153-6. Unique Identifier : AIDSLINE MED/95317466
 DE    Adenoviruses, Human/GENETICS/*IMMUNOLOGY  Administration, Oral  Animal
       AIDS Vaccines/ADVERSE EFFECTS/*ISOLATION & PURIF/STANDARDS  Chimpansee
       troglodytes  Female  *Genetic Vectors  Human  HIV
       Antibodies/BIOSYNTHESIS  HIV-1/GENETICS/*IMMUNOLOGY/PHYSIOLOGY
       Immunization Schedule  Safety  Vaccines, Synthetic/ADVERSE
       EFFECTS/*ISOLATION & PURIF/STANDARDS  Virus Replication  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).